New Horizons

Total Page:16

File Type:pdf, Size:1020Kb

New Horizons RWS Holdings plc RWS 2016 Annual Report New horizons RWS Holdings plc 2016 Annual Report RWS Holdings plc 2016 Annual Report Europa House Chiltern Park Chiltern Hill Chalfont St Peter Bucks SL9 9FG United Kingdom Telephone +44 (0) 1753 480 200 Facsimile +44 (0) 1753 480 280 Email [email protected] www.rws.com Contents 2 RWS Holdings plc 2016 Annual Report Contents Contents Company Overview 2 Financial Highlights 4 Chairman‘s Statement 6 Strategic Report 8 Board of Directors 12 Directors‘ Report 13 Statement of Directors‘ Responsibilities 16 Directors‘ Remuneration Report 17 Independent Auditor‘s Report to the Members of RWS Holdings plc 20 Financial Statements Consolidated Statement of Comprehensive Income 23 Consolidated Statement of Financial Position 24 Consolidated Statement of Changes in Equity 25 Consolidated Statement of Cash Flows 27 Notes to the Consolidated Financial Statements 28 Parent Company Financial Statements 54 Company Statement of Changes in Equity 57 Notes to the Company Financial Statements 58 Shareholder information 65 2 RWS Holdings plc 2016 Annual Report RWS Holdings plc 2016 Annual Report 1 Company overview RWS provides language and intellectual property services that support its clients in taking products from concept to market Research and Patenting development Information Patent Translation & Filing A comprehensive range of patent search The translation of patent and supporting and monitoring services which enable intellectual property documents in over clients to check if their intellectual property 200 language pairs and the management is novel, valid for an application or risks of multi-jurisdictional patent filing supported infringing upon existing patents. RWS has by our international web-based filing also established Patbase as one of the platform, inovia.com. world’s largest searchable commercial patent databases covering over 57 million patent families, designed by professional searchers and sold on a subscription basis. Technically and linguistically accurate Efficient processes supported by translations delivered to deadline sophisticated and proprietary technology Over 99% on time* Over 500 million words translated last year* 2 RWS Holdings plc 2016 Annual Report Our in-depth understanding of clients’ differing requirements as their product moves from research and development, to protection and commercialisation enables us to deliver consistently high-quality services at each stage of the product lifecycle, whilst giving RWS visibility of activity across the value chain Clinical Trials, Commercialisation Patient Outcomes and Litigation Life Sciences Technical & Commercial Translation A full suite of language solutions designed The translation of other specialist to support the entire life science industry. documents, from technical specifications The translation and linguistic validation and manuals to sensitive legal and of vital content for pharmaceutical, financial documents. Our work includes biotech and medical device companies the localisation of materials to ensure they including their clinical research are linguistically and culturally appropriate organisations, advertising agencies and in line with local regulations in multiple and other subcontractors. target markets. Excellent quality control and customer service Over 99% of customers happy with the quality of our services* *Source: RWS records RWS Holdings plc 2016 Annual Report 3 Financial Highlights 30 30.6 Over 80,000 (£m) patent and IP 20 22.7 22.1 21.0 documents and 17.2 16.2 14.5 10 14.6 13.9 Adjusted PBT 65,000 life 11.0 9.0 science projects 7.4 6.0 0 5.6 per year 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Market leader in intellectual property and A strong financial track record life science language and support services 7.8% increase in world-wide patent applications in 2015* c.800 employees 14% CAGR in US clinical ** including subject specialist trials 2011-2016 translators & checkers and project managers Strong reputation for quality and delivery with specialist staff supported by sophisticated technology Growing markets 13% sales growth at CTi since acquisition RWS has a strong track record of executing earnings accretive acquisitions *Source: World Intellectual Property Office, **Source: Number of clinical trials as recorded by ClinicalTrials.gov, a U.S. National Institutes of Health service 4 RWS Holdings plc 2016 Annual Report 5% Information 10% Commercial Translation 90% of revenues in highly specialised fields – intellectual property 20% and life sciences Life Sciences 65% Patent translation & filing Medical & Aerospace Chemical Automotive Energy Manufacturing Technology Pharma & Defence & Telecoms A diversified international, blue chip client base Strong cash generation supports progressive dividend policy 13 years of dividend increases Operations located to service customer needs globally RWS Holdings plc 2016 Annual Report 5 Chairman’s Statement I am pleased to report that RWS has delivered its generation. Other significant cash outlays included best year ever despite a far from robust global corporation tax of £5.2 million and dividends of economic backdrop. For the thirteenth consecutive £10.6 million. year since listing on AIM in November 2003, we have achieved growth in sales, underlying profits and Currency Effects and Hedging dividends, testimony to the strength of our market This year has been marked by considerable volatility positions in patent translations, intellectual property in global currency markets. This was compounded services and life sciences services. During the year, in the aftermath of the EU referendum in late June we have also continued to invest in those resources and the Group has benefitted from the resulting which can deliver future expansion. decline in sterling. RWS is a prolific exporter of its services meaning that over 85% of its revenues Results and Financial Review are non-sterling, its principal exposures being to The Group has achieved further significant progress the euro and the US dollar. The Group’s estimated in underlying operational performance, reflecting net exposure to the Euro has been hedged at an continued growth in the core patent translations average rate of 1 Euro = 83p for the whole of the business, together with growth in PatBase, China year to 30 September 2017. The average rate and Japan. In addition, the Group benefited from experienced over 2015-16 was 78.1p. Exposure a strong maiden contribution from CTi, the US life to the US dollar is largely offset by the five year sciences specialist it acquired in October 2015. US$45 million dollar loan drawn to acquire CTi. A material improvement in Group gross margins also contributed to our record results. Acquisition of a market leader in Life Sciences translations and linguistic validation Group sales advanced by 28% to £122.0 million The Group announced on 2 November 2015 that (2015: £95.2 million). Adjusted operating profit it had acquired the entire issued share capital before amortization of intangibles, share option of Corporate Translations Inc. (“CTi”) for a cash costs and acquisition expenses was up 40% at consideration of US$70 million. This acquisition was £32.0 million (2015: £22.9 million). in line with our stated strategy of complementing organic growth with selective acquisitions which Adjusted profit before tax, amortization of have growth potential in attractive sectors and/or intangibles, share option costs and exceptional geographies, offer excellent margins and enhance acquisition expenses increased by 35% to shareholder value. £30.6 million (2015: £22.7 million). This produced an increase of 35% in adjusted earnings per share to The acquisition of CTi established a significant Group 10.9p (2015: 8.1p). presence in the USA which the Board believes is the largest growth opportunity for RWS. CTi is one Reported profit before tax was £25.1 million (2015: of the world’s leading life sciences translation and £20.7 million). This result reflected significantly linguistic validation providers. It enjoys a preferred greater amortization of intangibles largely driven by supplier relationship with many of its key clients, the CTi acquisition and totalling £4.6 million (2015: with extraordinary penetration of the blue chip life £1.6 million), offset by lower share based payment sciences community. CTi’s greater scale, combined costs. Basic earnings per share were 9.0p (2015: with the existing RWS specialist divisions, provided 7.3p), a rise of 23%. The Group’s effective tax rate a step change in the Group’s competitive standing was 22.9% (2015: 24.8%). amongst the major pharmaceutical groups and contract research organisations, whilst RWS’ strong As of 30 September 2016, shareholders’ funds foothold in Europe is already supporting CTi’s had reached £108.7 million (2015: £85.7 million). expansion into the European life sciences sector. At 1 October 2015 the Group had net cash of £30.6 million. The Group ended the 2016 financial Funding for the acquisition was via a combination of year with net debt of only £1.5 million, after the a US$45 million five-year bank loan and the Group’s £47.1 million cash consideration for CTi which was internal cash resources. acquired at the end of October 2015, demonstrating the Group’s continued strong underlying cash 6 RWS Holdings plc 2016 Annual Report Chairman’s Statement (continued) The acquisition of CTi has been immediately People and significantly earnings enhancing, with the The very nature of the Group’s activities dictate that US$70 million consideration based upon CTi reporting it will always be dependent upon the quality and in excess of US$7 million EBITDA for the year ended dedication of its entire staff to meet the demands 31 December 2015. We have now completed the for high quality and timely delivery required by its integration of CTi with our Medical Translation worldwide clients. Group headcount reached 792 full Division, which included the linguistic validation time equivalents at the year-end (2015: 621), which specialist PharmaQuest, and we now report on it as includes the 143 CTi employees who joined the part of our combined life sciences activities. We were Group upon acquisition.
Recommended publications
  • The 2017 Global Patent & IP Trends Indicator
    Front cover An in-depth look at the foreign filing strategies of global patent owners June 2017 The 2017 Global Patent & IP Trends Indicator 1. Introduction The Global Patent & IP Trends Indicator is an annual report issued by RWS inovia, the world leader in foreign patent filing, IP translation, patent search and database services. This year’s survey confirms something our readers all know – it is a The main findings of the 2017 report tough job being an in-house IP counsel. They are expected to keep track of IP developments and trends not only locally, but internationally. In- indicate overall patent activity and house counsel must also be able to predict laws and the consequences international filing rates on the rise, with of court decisions well into the future. Moreover, all of this needs to be the upcoming European Unitary Patent done on a smaller budget, set by a CFO who may have little appreciation of the nuances of IP law. on the minds of patent professionals around the world. RWS inovia’s Global Patent & IP Trends Indicator gives you a view into what your IP colleagues are doing to keep up with the changing patent landscape. If you are in private practice, you will find plenty of insight into what your in-house clients are facing, so you can better advise and serve them. If your budget has been cut again – you are not alone. Take a look at the stats on page 21 that show IP budgets are still under pressure. More importantly, consider the list of approaches on page 25 showing how others have tried to do more with less.
    [Show full text]
  • The Top 100 Language Service Providers: 2013 by Donald A
    This six-page extract from “The Language Services Market: 2013” is subject to Common Sense Advisory’s standard terms of use. Unauthorized reproduction and distribution are strictly prohibited. The Top 100 Language Service Providers: 2013 by Donald A. DePalma and Vijayalaxmi Hegde This brief presents the world’s leading providers of translation, localization, and interpreting services. Because there were several instances of companies reporting identical revenue, the list includes three ties, resulting in 103 companies claiming or sharing the top 100 spots (see Table 1). The two-letter country codes listed correspond to ISO 3166-1 alpha 2, the most commonly used abbreviations. Company HQ Country Status 1 Lionbridge Technologies US Public 2 HP ACG FR Public 3 TransPerfect / Translations.com US Private 4 SDL UK Public 5 LanguageLine Solutions US Private 6 euroscript international S.A. LU Private 7 STAR Group CH Private 8 Welocalize, Inc. US Private 9 RWS Group UK Public 10 ManpowerGroup Solution – Language Services US Public 11 CLS Communication CH Private 12 Honyaku Center Inc. JP Public 13 YAMAGATA INTECH Corporation JP Private 14 Moravia CZ Private 15 thebigword Group UK Private 16 Pactera Technology International Ltd CN Public 17 Hogarth Worldwide UK Private 18 Semantix SE Private 19 Logos Group IT Private 20 CyraCom International, Inc. US Private 21 ONCALL Language Services Pty Ltd AU Private Copyright © 2013 by Common Sense Advisory, Inc. 31 May 2013 Unauthorized Reproduction & Distribution Prohibited www.commonsenseadvisory.com The Top 100 Language Service Providers: 2013 2 Company HQ Country Status 22 KERN Global Language Services DE Private 23 Språkservice Sverige AB SE Private 24 CSOFT International, Ltd.
    [Show full text]
  • Read Our 2019 Benefit Corporation Report
    2019 BENEFIT CORPORATION REPORT 2019 Benefit Corporation Report | 1 Dear Friends, I am delighted to share with you our 2019 Benefit Corporation Report—our third since becoming a New York State Benefit Corporation in 2017. A benefit corporation is one that has legally committed to higher standards of purpose, accountability and transparency. For EILEEN FISHER, this means we are designing clothing with minimal environmental and social harm; creating an inclusive workplace; empowering women and girls, supporting the fair treatment of all people and preserving the environment; and advancing ethical business practices through collaborations in the fashion industry. In 2019, we continued our VISION2020 work toward greater environmental sustainability and human well-being within our supply chain. We also introduced our new grant program, “Supporting Women in Environmental Justice.” And we embarked upon a new Diversity and Inclusion initiative to build a stronger workplace culture for our employees and customers. As we enter a new decade, we remain committed to conducting “business as a movement.” If you have any comments or questions, please direct them to [email protected]. Thank you, 2019 Benefit Corporation Report | 2 Our Purpose We design for simplicity and wholeness—to inspire joy and connection in women around the world. Our Values • We are authentic. • We thrive in connection. • We trust each other. • We innovate through creativity. • We are committed to the health of the whole. • We are united by purpose. 2019 Benefit Corporation Report | 3 Benefit 1 We are committed to designing clothing that creates minimal environmental and social impact. 2019 Benefit Corporation Report | 4 Materials We aim to use sustainable materials in 100% of our products.
    [Show full text]
  • 2.7 Announcement
    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS ANNOUNCEMENT IS DEEMED BY RWS AND SDL TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION NO 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY INVESTMENT DECISION IN RELATION TO THE NEW RWS SHARES EXCEPT ON THE BASIS OF INFORMATION IN THE SCHEME DOCUMENT AND THE RWS CIRCULAR WHICH ARE PROPOSED TO BE PUBLISHED IN DUE COURSE. FOR IMMEDIATE RELEASE 27 August 2020 Recommended All-Share Combination of RWS Holdings plc (“RWS”) and SDL plc (“SDL”) Creating the world’s leading language services and technology group The RWS Board and the SDL Board are pleased to announce that they have reached agreement on the terms of a recommended all-share combination of RWS and SDL, pursuant to which RWS will acquire the entire issued and to be issued share capital of SDL, to be effected by means of a court-sanctioned scheme of arrangement between SDL and SDL Scheme Shareholders under Part 26 of the Companies Act (the “Combination” to form the “Combined Group”). The Combination will create a truly global provider of language services and technology. The Combined Group will be a broad-based, well-funded business benefitting from increased scale, superior capabilities, an expanded geographic footprint and a highly experienced management team.
    [Show full text]
  • RWS Holdings Plc Results for the Year Ended 30 September 2020 A
    For immediate release 10 December 2020 RWS Holdings plc Results for the year ended 30 September 2020 A resilient full year performance, in line with market expectations RWS Holdings plc ("RWS", "the Group"), the world's leading provider of language services and language technology, today announces its final results for the year ended 30 September 2020. Financial highlights 2020 2019 Change Revenue £355.8m £355.7m +0.02% Adjusted profit before tax1 £70.2m £74.2m -5.5% Profit before tax £58.7m £57.7m +1.7% Adjusted earnings per share1 19.9p 21.3p -6.6% Basic earnings per share 16.9p 16.5p +2.4% Dividend Proposed final 7.25p 7.00p +3.6% Total for year 9.00p 8.75p +2.9% Cash conversion2 100.1% 94.6% Net debt1 £15.1m £36.8m -41.2% 1 RWS uses adjusted results as key performance indicators as the Directors believe that these provide a more consistent measure of operating performance by adjusting for acquisition related charges and significant one-off or non-cash items. Adjusted operating profit is stated before interest, amortization of acquired intangibles, share based payment expense, acquisition costs and exceptional items. Adjusted profit before tax is stated before amortization of acquired intangibles, share based payment expense, acquisition costs and exceptional items. Adjusted earnings per share adjusts for amortization of acquired intangibles, share based payment expense, acquisition costs and exceptional items, net of any associated tax effects. Net debt comprises loans less cash and cash equivalents excluding lease liabilities. 2 Cash conversion is free cash flow expressed as a percentage of Adjusted net income.
    [Show full text]
  • The 2016 Global Patent & IP Trends Indicator
    Front cover Offices worldwide in North America, Europe & APAC. The 2016 Global Patent & IP Trends Indicator An in-depth look at the foreign filing strategies of U.S. and European patent owners Inside front cover Text page 1 The Global Patent & IP Trends Indicator is an annual report issued by RWS inovia, the global leader in foreign patent filing, IP translations and search services. Now in its seventh year, the Indicator is a go-to resource for identifying the trends having the greatest impact on the foreign filing strategies of patentees around the world. The survey was conducted by RWS inovia in May 2016 and includes responses from over 100 companies and universities in the United States and Europe. The IP Indicator has become a benchmark report in the patent industry, providing insight and guidance for those looking to file internationally. This report summarizes the results and trends identified in those that participated. Contents Introduction 1 2015 in review 3 Foreign filing & global outlook 6 IP budgets & workflow changes 12 Outlook for 2016 16 Text page 1 Introduction Respondents represent a diverse range of industries and sizes from small businesses filing a single patent family to multinational corporations filing more than 1,000 patents in 2015. All respondents share one common thread and are involved in the strategy and planning of patent filing activities at their respective organizations. Job functions range from Head of Global Patent Operations to General Counsel to CEO. Respondent overview 68% 32% U.S. respondents European
    [Show full text]
  • German > English 46 Burcott Road, Wells, ITI Associate Member
    Martin Lee BSc (Econ), DipTransIoLET German > English 46 Burcott Road, Wells, ITI Associate Member Somerset, UK. BA5 2EQ [email protected] + 44 (0) 1749 675161 www.doubledeckertransations.co.uk General: I have extensive knowledge and experience in the area of business development and education. Specialisms: Market research Assessment of business start ups Market analysis Measures adopted to improve efficiency Management of product portfolios Assessment of lean production techniques Marketing mix Communication structures in organizations Development of marketing strategies Staff retention Promotional techniques Training Financial reporting and analysis Teamwork and leadership. Internal management accounting Small and large scale production methods Commercial Contracts Business impact of government macroeconomic policy Experience (The following are recently completed projects) Press release information B2B Brüggen, Germany Various legal texts NOWAK, Regensburg Commercial rental contract Translation Doctor, London Press release information St Clair, Dortmund Website / Marketing information Tradelice, Paris Promotional material Translata, Bratislava Internal company procedures WAW Words at Work Hamburg Employment Contracts Dialekta, Sofia Theatre project concepts Bochert Translations, Berlin Professorship Job Adverts Eriksen Translations Inc., NY. Education: I achieved a First Class Honors Degree in German and Business, receiving a distinction in my oral work and the German Prize from the University. I also hold the Chartered Institute of Linguists Diploma in Translation, with specalisms in Business and Social Science, and a Post Graduate Certificate in Modern Languages education. Language: German I have lived and worked in Germany as an English Language Tutor for the Wilhelm-Raabe- Gymnasium in Hanover. I completed a placement with Schering AG Berlin-Wedding. I have also carried out general work for job agencies in Germany.
    [Show full text]
  • RWS Circular
    THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to any aspect of the proposals referred to in this document or as to the action you should take, you should seek your own advice from a stockbroker, solicitor, accountant or other professional independent adviser immediately who is duly authorised under the Financial Services and Markets Act 2000 (as amended) if you are resident in the United Kingdom or, if not, from another appropriately authorised professional independent adviser in the relevant jurisdiction. If you have sold or otherwise transferred all of your RWS Shares, please forward this document and any accompanying documents as soon as possible to the purchaser or transferee, or to the person who arranged the sale or transfer so they can pass these documents to the person who now holds the RWS Shares. RWS HOLDINGS PLC (incorporated and registered in England and Wales with registered number 03002645) NOTICE OF GENERAL MEETING TO BE HELD AT 10.00 A.M. ON 9 OCTOBER 2020 IN RELATION TO THE RECOMMENDED ALL-SHARE COMBINATION WITH SDL PLC Notice of the RWS General Meeting to be held at 10.00 a.m. on 9 October 2020 at the offices of Europa House, Chiltern Park, Chiltern Hill, Chalfont St Peter, Buckinghamshire, SL9 9FG is set out at the end of this document. Given the evolving situation regarding Covid-19 and the changing restrictions on social contact, public gatherings and non-essential travel, RWS Shareholders will not be permitted to attend the RWS General Meeting in person, save for those RWS Shareholders permitted by the chairman of the meeting to attend to establish a quorum.
    [Show full text]
  • The Size and State of the Language Services Industry, Including Ranking of Top 100 Lsps by Revenue
    The size and state of the language services industry, including ranking of top 100 LSPs by revenue. March, 2018 First edition ABOUT NIMDZI Who we are The language services industry is growing and there is no end in sight. For your company to dominate the competition and be ahead of the game, you require insight – and that is exactly where we come in. We come from diverse backgrounds in the language industry. We are a market research and international consulting company made up of analysts, consultants, LSP experts, and researchers. But we are all connected with one united goal – Helping our clients succeed. And yes. We know the industry. What we do With a global team management approach, we work directly with you, learning the ins and outs of your business so that we can help to customize and tailor your business needs on the global stage. When you localize your message to prospective global customers, you reach them on a much deeper level and that only means one thing – customers are engaged and interested. We help you to better understand and connect with your demographic. We build actionable insights and reports that cater specifically to your products and services. We provide the window into the ever-changing translation and localization industries. Working with us means building relationships with influential players – an essential part of penetrating your market. The future lies directly in the global market. We get inside the head of the localization users and focus on factors that are important to them. We research. We report. We advise.
    [Show full text]
  • Translation Memory Management
    Translation Memory Management SDL Trados Studio 2021 SR1 November 2020 Legal notice Copyright and trademark information relating to this product release. Copyright © 2000–2021 SDL as part of the RWS Holdings Plc group of companies ("RWS Group"). SDL means SDL Limited and its subsidiaries and affiliates. All intellectual property rights contained herein are the sole and exclusive rights of SDL. All references to SDL shall mean SDL Limited and its subsidiaries and affiliates details of which can be obtained upon written request. All rights reserved. Unless explicitly stated otherwise, all intellectual property rights including those in copyright in the content of this website and documentation are owned by or controlled for these purposes by SDL. Except as otherwise expressly permitted hereunder or in accordance with copyright legislation, the content of this site, and/or the documentation may not be copied, reproduced, re- published, downloaded, posted, broadcast or transmitted in any way without the express written permission of SDL. SDL Trados Studio is a registered trademark of SDL. All other trademarks are the property of their respective owners. The names of other companies and products mentioned herein may be the trade- marks of their respective owners. Unless stated to the contrary, no association with any other company or product is intended or should be inferred. This product may include open source or similar third-party software, details of which can be found by clicking the following link: “Acknowledgments ” on page 35 . Although RWS Group takes all reasonable measures to provide accurate and comprehensive information about the product, this information is provided as-is and all warranties, conditions or other terms concerning the documentation whether express or implied by statute, common law or otherwise (including those relating to satisfactory quality and fitness for purposes) are excluded to the extent permitted by law.
    [Show full text]
  • RWS Holdings Plc ("The Group")
    RWS GROUP For immediate release 2 June 2015 RWS Holdings plc ("the Group") Half year report for the six months to 31 March 2015 Solid performance from core business RWS Holdings plc (RWS), the world's leading provider of intellectual property support services (patent translations, searches and international patent filing solutions), and commercial translations, today announces its half year results for the six months ended 31 March 2015. Financial Highlights: Sales for the period £45.4m (H1 2014: £46.9m) ○ Sales on a constant currency basis were £46.9m (H1 2014: £46.9m) Adjusted profit before tax* was flat at £10.8m (H1 2014: £10.8m) Adjusted earnings per share* was up by 3% at 3.9p (H1 2014: 3.8p), after 5 for 1 share split Interim dividend increased by 5% to 1.03p (H1 2014: 0.98p), after 5 for 1 share split Net cash at period end £21.5m (H1 2014: £14.9m) * before amortization of intangibles, and share option costs Operational Highlights: Solid revenues in the core patent translations business on a constant currency basis: ○ Further growth in China and progress in Japan ○ Strong pipeline of new clients; longer than normal lead times for conversion to sales Commercial translation business was up 2% on a constant currency basis reflecting growth in Germany partially offset by lower revenues in the UK in light of an increasingly competitive environment Information search revenues reverted to normal patterns after exceptionally strong H1 2014 PatBase subscription revenues increased by 7% Intellectual property support services now
    [Show full text]
  • RWS Holdings Plc
    RWS GROUP For immediate release 11 October 2016 RWS Holdings plc Year End Trading Statement RWS Holdings plc ("RWS", "the Group"), the world's leading provider of intellectual property support services (patent translations, international patent filing solutions and searches), commercial translations and linguistic validation, today provides an update on trading for the year ended 30 September 2016, ahead of the announcement of its full year results, which is expected on 6 December 2016. Trading & Financial Update RWS has enjoyed its best year ever and the Board expects Group revenues to be not less than £122 million compared to £95.2 million in 2015, an increase of at least 28%. This strong performance has been driven by the core translations activities, an excellent eleven-month contribution from Corporate Translations Inc. (”CTi”), the newly acquired specialist in life sciences translation and linguistic validation, and an improving currency environment. Adjusted profit before tax (before amortisation of intangibles, share option costs and exceptional CTi acquisition costs) is expected to be not less than £30.5 million (2015: £22.7 million), an increase of 34%, reflecting the benefits of improved gross margins, the CTi acquisition and currency tailwinds. The core translation business has made significant progress; PatBase continues to perform well, growing by a further 7%; and China, Japan and Switzerland delivered strong performances. The Group announced the acquisition of CTi, based in Connecticut, USA, on 2 November 2015. CTi is the world’s leading translation company focussing entirely upon life sciences translation and linguistic validation. As highlighted at the half year, the Group’s UK life sciences activities have been integrated into CTi to form a larger unit with production sites across continents to expand its market leading position with major pharmaceutical groups and contract research organisations in Europe.
    [Show full text]